https://ba.prisysbiotech.com/ Ne - Ljudski Primate Istraživanje Platforma & CRO | PRISYS Biotech https://ba.prisysbiotech.com/uploads/39406/logo.png https://ba.prisysbiotech.com/biosafety-research/ Biosafety Research https://ba.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://ba.prisysbiotech.com/nhp-pharmacology/ NHP Pharmacology https://ba.prisysbiotech.com/uploads/39406/list/n20240227154733ebf63.jpg https://ba.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://ba.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://ba.prisysbiotech.com/safety-evaluation/ Safety Evaluation https://ba.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://ba.prisysbiotech.com/translation-research/ Translation Research https://ba.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://ba.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://ba.prisysbiotech.com/uploads/39406/page/small/pharmacokineticsa44cd.jpg Pharmacokinetics https://ba.prisysbiotech.com/uploads/39406/page/pharmacokineticsa44cd.jpg https://ba.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://ba.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://ba.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://ba.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://ba.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://ba.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-teste7c22.jpg Dose Range Finding Test https://ba.prisysbiotech.com/uploads/39406/page/dose-range-finding-teste7c22.jpg https://ba.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://ba.prisysbiotech.com/uploads/39406/page/small/what-is-a-nhp-study0fe0f.jpg What Is A NHP Study https://ba.prisysbiotech.com/uploads/39406/page/what-is-a-nhp-study0fe0f.jpg https://ba.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://ba.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/pulmonary-artery-hypertension-embolism9d266a3e-e0d5-46d2-85d6-aad09f286515.jpg Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/pulmonary-artery-hypertension-embolism9d266a3e-e0d5-46d2-85d6-aad09f286515.jpg https://ba.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://ba.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://ba.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://ba.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://ba.prisysbiotech.com/uploads/202339406/small/new-and-modified-applicationsab01b425-decb-46a1-90d1-e5fee60f1327.jpg New And Modified Applications https://ba.prisysbiotech.com/uploads/202339406/new-and-modified-applicationsab01b425-decb-46a1-90d1-e5fee60f1327.jpg https://ba.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://ba.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://ba.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://ba.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://ba.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://ba.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/glaucoma-nonhuman-primates-disease-model092df254-f018-4636-a429-8344948a9978.jpg Glaucoma Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/glaucoma-nonhuman-primates-disease-model092df254-f018-4636-a429-8344948a9978.jpg https://ba.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://ba.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://ba.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://ba.prisysbiotech.com/uploads/202339406/small/nhp-asthma-atopic-dermatitis-model6bc15051-9b18-470b-a3ed-3a035fb26acc.jpg NHP Asthma/atopic Dermatitis Model https://ba.prisysbiotech.com/uploads/202339406/nhp-asthma-atopic-dermatitis-model6bc15051-9b18-470b-a3ed-3a035fb26acc.jpg https://ba.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html Acute Myocardial Infarction/Heart Failure Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/acute-myocardial-infarction-heart-failure3d3bf8b7-5a0c-4f9d-8841-7f98a51cf834.jpg Acute Myocardial Infarction/Heart Failure Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/acute-myocardial-infarction-heart-failure3d3bf8b7-5a0c-4f9d-8841-7f98a51cf834.jpg https://ba.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://ba.prisysbiotech.com/uploads/202339406/small/nhp-chronic-obstructive-pulmonary-disease08000f1b-42f7-4c7d-9ba5-6f15c54993c9.jpg NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://ba.prisysbiotech.com/uploads/202339406/nhp-chronic-obstructive-pulmonary-disease08000f1b-42f7-4c7d-9ba5-6f15c54993c9.jpg https://ba.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://ba.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://ba.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://ba.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://ba.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://ba.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://ba.prisysbiotech.com/uploads/202339406/small/translational-studiesd565144e-fcec-4437-afeb-42982ae7bab9.jpg Translational Studies https://ba.prisysbiotech.com/uploads/202339406/translational-studiesd565144e-fcec-4437-afeb-42982ae7bab9.jpg https://ba.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://ba.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://ba.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://ba.prisysbiotech.com/uploads/202339406/small/nhp-non-alcoholic-steatohepatitis-nash-model7332a6f4-bc77-45be-bf2b-07178c46a62a.jpg NHP Non-Alcoholic Steatohepatitis (NASH) Model https://ba.prisysbiotech.com/uploads/202339406/nhp-non-alcoholic-steatohepatitis-nash-model7332a6f4-bc77-45be-bf2b-07178c46a62a.jpg https://ba.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/uveitis-nonhuman-primates-disease-model0ba7fdbf-75a4-42f7-8990-e9daa0c176b0.jpg Uveitis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/uveitis-nonhuman-primates-disease-model0ba7fdbf-75a4-42f7-8990-e9daa0c176b0.jpg https://ba.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/myopia-hyperopia-nhp-modela0553861-d7d5-4d4f-af65-68d25533d6ef.jpg Myopia Hyperopia Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/myopia-hyperopia-nhp-modela0553861-d7d5-4d4f-af65-68d25533d6ef.jpg https://ba.prisysbiotech.com/pk-pd-adme/adme.html ADME https://ba.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://ba.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://ba.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity https://ba.prisysbiotech.com/uploads/202339406/small/immunotoxicitya758bdcf-a01c-4970-a80d-758e345ae77f.jpg Immunotoxicity https://ba.prisysbiotech.com/uploads/202339406/immunotoxicitya758bdcf-a01c-4970-a80d-758e345ae77f.jpg https://ba.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://ba.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/neuropathic-pain-nhp-modela385dae9-a466-42bb-9982-13db42e0581b.jpg Neuropathic Pain Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/neuropathic-pain-nhp-modela385dae9-a466-42bb-9982-13db42e0581b.jpg https://ba.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://ba.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://ba.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://ba.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://ba.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://ba.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/inflammatory-bowel-nhp-disease-modelf4c414ff-a224-4634-a994-b8ba7a18a488.jpg Inflammatory Bowel Disease Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/inflammatory-bowel-nhp-disease-modelf4c414ff-a224-4634-a994-b8ba7a18a488.jpg https://ba.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/amd-nonhuman-primates-disease-modelf663a012-d546-4fbb-8d78-834cea736255.jpg AMD Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/amd-nonhuman-primates-disease-modelf663a012-d546-4fbb-8d78-834cea736255.jpg https://ba.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://ba.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://ba.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://ba.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://ba.prisysbiotech.com/uploads/39406/toxicokinetics70843.jpg Toxicokinetics https://ba.prisysbiotech.com/uploads/39406/toxicokinetics70843.jpg https://ba.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://ba.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://ba.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://ba.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://ba.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://ba.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://ba.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://ba.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://ba.prisysbiotech.com/translation-research/clinical-imaging.html Clinical Imaging https://ba.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://ba.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://ba.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://ba.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://ba.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://ba.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://ba.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://ba.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Model dijabetes melitusa tipa 2 https://ba.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Model dijabetes melitusa tipa 2 https://ba.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://ba.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://ba.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://ba.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://ba.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://ba.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://ba.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://ba.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://ba.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://ba.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://ba.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://ba.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://ba.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://ba.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://ba.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://ba.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://ba.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://ba.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://ba.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://ba.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://ba.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://ba.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://ba.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://ba.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://ba.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://ba.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://ba.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://ba.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://ba.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://ba.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://ba.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://ba.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://ba.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://ba.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://ba.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://ba.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://ba.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://ba.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://ba.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://ba.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://ba.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://ba.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://ba.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://ba.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://ba.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://ba.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://ba.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://ba.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://ba.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724208134693888.html Rekapitulacija 2025: Kako Prisys redefinira translacionu pouzdanost u istraživanju NHP-a https://ba.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://ba.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17555460205224960.html NHP - Farmakologija i farmakodinamičke usluge sa sjedištem u NHP-u|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17528841362629632.html Upoznajte Pririsys Biotech na nadolazećim EU Roadshow: septembar 2025. godine https://ba.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://ba.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17447964097995776.html Prisys Biotech - 2025. pregled sredinom godine https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17245532409619456.html Upoznajte Prisijeve u predstojećem nas-Roadshowu u martu 2025. godine https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84036157.html PRISYS godišnji izvještaj 2024: Unapređenje NHP modela i pretkliničkih istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://ba.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77721111.html Prisys Biotech 2024 Q2 Newsletter - Unaprijeđeno pretkliničko istraživanje i razvoj za CNS terapeutike s PRISYS unakrsno reaktivnim modelima https://ba.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://ba.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120834.html Targeted Therapy For Parkinson's Disease: Breakthrough in Real-Time MRI-Guided Stem Cell Transplantation https://ba.prisysbiotech.com/uploads/39406/news/n202409061001122b75a.jpg https://ba.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724211855959040.html Kada bol postane sjećanje: emocionalni pokretači kroničnog bola i prednost NHP modela|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://ba.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724211816047616.html Više-Procjena bola u krajnjoj tački: budućnost razvoja analgetičkih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://ba.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724209139000320.html Zašto toliko analgetika ne uspije u pretkliničkim ispitivanjima? Odgovor leži u tome kako mjerimo bol https://ba.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://ba.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724206769021952.html Dizajn vremenske tačke uzorkovanja krvi u farmakokinetičkim (PK) studijama|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://ba.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724206741054464.html PK statistika: Parametri bez-kompartmentalne analize (NCA) i pretkliničke primjene https://ba.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://ba.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724206303896576.html Zašto su modeli ne-ljudskih primata kritični za CNS oligonukleotidnu terapiju https://ba.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://ba.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724206259528704.html Metabolizam mokraćne kiseline kod ljudi protiv majmuna: translacijske implikacije za razvoj lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://ba.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724205995353088.html Ne-MASH-model pridružene fibroze jetre|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://ba.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724206207738880.html Zašto je IMRI{0}}navođena isporuka lijekova za mozak ključna za precizno ciljanje u NHP studijama https://ba.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://ba.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674622059439104.html NHP 3D sistem za analizu ponašanja bez markera|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://ba.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674622088897536.html LPS-indukovana akutna upala pluća (ALI) NHP model|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://ba.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674622124712960.html HDM+SEB-Model induciranog atopijskog dermatitisa (AtD) kod Cynomolgus majmuna https://ba.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://ba.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674626702664704.html Objašnjenje PK modela sa jednim- do više-odjeljaka|NHP Pharmacokinetics|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://ba.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674626422547456.html Kako odabrati pouzdanu pretkliničku CRO|Ključni kriterijumi za biotehnološke kompanije|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://ba.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674622005470208.html Translacijska CAR-T evaluacija: In Vitro ekspertiza i podrška studijama NHP — Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://ba.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674622184580096.html Zašto više od 90% kandidata za lijekove za CNS ne uspije u kliničkim ispitivanjima? https://ba.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://ba.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674622611317760.html Pretklinički modeli Parkinsonove bolesti: Vodič za odabir neurotoksina, genetskih i NHP modela|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://ba.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674622114538496.html Visoko{0}}precizne isporuke lijekova i NHP platforme za prevođenje vođene AI{1}} https://ba.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://ba.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625188821148672.html NHP imunološki modeli vođeni Th17|Translacijska autoimunska istraživanja u Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://ba.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625189014381568.html NHP BehaviorAtlas® sistem zasnovan na AI- 3D platforma za analizu ponašanja|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://ba.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625190657991680.html RFP šablon za NHP studije|Ubrzajte efikasnost pretkliničkih istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://ba.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625189873984512.html Model bola pri hladnoj alodiniji u Cynomolgus Monkeys|Prisys Biotechnologies https://ba.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://ba.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625188888781824.html MRI-Vođena platforma za intracerebralnu isporuku lijekova|Prisys Biotech CNS Research https://ba.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://ba.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625189711586304.html NHP modeli respiratornih bolesti i platforma za isporuku lijekova u disajnim putevima|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://ba.prisysbiotech.com/news/nhp-renal-biopsy-17625189200782336.html NHP platforma za biopsiju bubrega i modeli bolesti bubrega|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251022172158e338d.jpg https://ba.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625189180040192.html PK studije i ciljana isporuka lijekova|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://ba.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625188964852736.html NHP Research and AI-bazirana platforma za analizu ponašanja Prisys Biotechnologies https://ba.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://ba.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625189889156096.html Tehnologija isporuke iz nosa-u-mozak (N2B) za istraživanje CNS-a|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://ba.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625188730659840.html SHR-2004: Proboj u prevenciji VTE za pacijente s rakom jajnika – priča o uspjehu Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://ba.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538079422735360.html Cynomolgus & Rhesus Monkey Modele|Prisys Biotech preklinički CRO https://ba.prisysbiotech.com/uploads/39406/news/n202509191421539fa9b.jpg https://ba.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17528841183060992.html Idiopatska plućna fibroza (IPF) NHP model|Prisys Biotech preklinički CRO https://ba.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17528841352913920.html Cynomolgus Monkey studije biodistribucije|Prisys Biotech preklinički CRO https://ba.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://ba.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17528841455133696.html Prisys BIOTECH NHP modeli za hematologiju i istraživanje hoda https://ba.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://ba.prisysbiotech.com/news/the-importance-of-administration-volume-17528841231115264.html Važnost volumena administracije u pretkliničkim studijama|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://ba.prisysbiotech.com/news/brain-targeted-drug-delivery-17528841258165248.html Mozak - ciljana dostava droga|Prisys Biotech preklinički NHP Istraživanje https://ba.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://ba.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17528879861244928.html Razvoj droga ADC|Translacijski PK / PD okvir u prekliničkih NHP studija https://ba.prisysbiotech.com/uploads/39406/news/n2025081814020269ffa.jpg https://ba.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17496371874505728.html NHP modeli boli za prelazni lijek otkriće|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://ba.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17496372141908992.html Serum vs. PLASMA: Odabir optimalne matrice za pretkliničku bioanalizu https://ba.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://ba.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17496371800794112.html Predliničke smjernice za doziranje: IV & PO zapremina, pH i osmolarnost za tačan PK u NHP-u i drugim vrstama https://ba.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://ba.prisysbiotech.com/news/nhp-copd-model-17496371843638272.html Top COPD Istraživački modeli i izvrsnost respiratorne platforme od strane Prissa https://ba.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://ba.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17496371690775552.html NHP Akutni model krvarenja: ključni alat za ubrzavanje razvoja lijekova za ubrzavanje romana https://ba.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://ba.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17496371666560000.html Istraživanje Pruritus: PRISSY BIOTECHOV IL-31 IN-31 NHP model za ocjenu anti-svrbenih terapija https://ba.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://ba.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17447964031329280.html Vodič za procjenu antitela protiv droge (ADA) https://ba.prisysbiotech.com/uploads/39406/news/n2025071015011851653.jpg https://ba.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17447964101960704.html Respiratorne terapije: Prison BIOTECH-ova integrirana NHP platforma za pretkliničku istraživanje https://ba.prisysbiotech.com/uploads/39406/news/n202507080951326501f.gif https://ba.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17447964024398848.html NHP modeli boli: ubrzanje analgetskog razvoja lijekova u Pririsy Biotech https://ba.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://ba.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17447986329428992.html Model NHP modela za podršku razvoju droga u složenim bolestima https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/news/key-considerations-for-dosing-volume-17447963991827456.html Ključna razmatranja za doziranje volumena, pH i formulacija u životinjskim modelima https://ba.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://ba.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17447963751343104.html Projektni egzozomi: Revolucionariziranje poremećaja lijeka za CNS poremećaje - preklinički uvidi iz Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20250617131838d8cea.jpg https://ba.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17447963707974656.html Vodeći principi za izbor životinjske vrste u toksikološkim studijama na likovnoj kiselini https://ba.prisysbiotech.com/uploads/39406/news/n202506131705069d4cc.jpg https://ba.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17447963857937408.html Prison Biotech-ov napredni DSA i IMRI za studije hematološke, vaskularne i bubrežne bolesti https://ba.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17447963787289600.html Modeli bolova Cynomolgus Monkey: Power za prevođenje istraživanja za proboj Ion kanala Therapeutics https://ba.prisysbiotech.com/uploads/39406/news/n20250605125053411da.jpg https://ba.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17447963947836416.html Istraživanje atopijskog dermatitisa: Prison BIOTECH-ov nečovječni primat (NHP) model https://ba.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://ba.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17447963724768256.html PRISSY BIOTECHOV NHP atopijski dermatitis model za razvoj lijekova protiv prurita https://ba.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://ba.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17387991795901440.html Projektiranje studija na životinjama: Ključna razmatranja za pretklinički istraživački uspjeh https://ba.prisysbiotech.com/uploads/39406/news/n2025052317011698995.jpg https://ba.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17387991594427392.html Atopijski dermatitis: kako modeli Cynomolgus majmun avans preciznosti terapeutike https://ba.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://ba.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17387991477396480.html Istraživanje astme: Zašto su modeli ne-ljudskih primata ključni za razvoj novih droga https://ba.prisysbiotech.com/uploads/39406/news/n20250512174400b2bec.jpg https://ba.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17387991449068544.html Razumijevanje antisense oligonucleotide (ASO) farmakokinetika: ključni faktori apsorpcije i distribucije https://ba.prisysbiotech.com/uploads/39406/news/n202505081658273697e.jpg https://ba.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17387991724221440.html NHP Inhalacijske studije za biološku: Prisijeve specijalizirane pretklične CRO usluge https://ba.prisysbiotech.com/uploads/39406/news/n2025043015244899508.jpg https://ba.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17387991490913280.html Napredne prekliničkih studija udisanja: tehničke mogućnosti i stručnost u Prisysu Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202504291646054725d.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17387991565755392.html Razumijevanje farmakokinetike (PK): ključni parametri i aplikacije u razvoju lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://ba.prisysbiotech.com/news/intracerebroventricular-icv-injection-17387991793837056.html INTRACEREBROVENTRICULAR (ICV) INJEKCIJA: Precizna CNS isporuka za pretkliničku istraživanje https://ba.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://ba.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17387991692960768.html INTRACEREBRAL (ICM) ubrizgavanje: precizno ciljanje za CNS terapeutike - preklinički razmatranja https://ba.prisysbiotech.com/uploads/39406/news/n202504180938433bda1.jpg https://ba.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17387991647839232.html INTRATECAL (IT) ubrizgavanje: direktna CNS-ova ruta za napredne terapije - preklinički razmatranja https://ba.prisysbiotech.com/uploads/39406/news/n202504160948404ad29.jpg https://ba.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17387991411696640.html Unapređenje Parkinsonove istraživanja bolesti sa NHP modelom https://ba.prisysbiotech.com/uploads/39406/news/n202504111626379b25c.jpg https://ba.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17387991654573056.html Preklinički PK \/ PD Studies & NHP modeli za razvoj droga|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2025040809451573e94.png https://ba.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17302883327534080.html Ciljanje interleukina -31 (Il -31): roman granica u razvoju droge autoimune bolesti - Prisys Biotech NHP modeli za pretkliničku resegure https://ba.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://ba.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17301885489521664.html Neklinička imunotoksičnost Procjena: Strategija, ključna razmatranja i izbor metode https://img01.v15cdn.com/gallery/4x3/232.webp https://ba.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17301885333726208.html Mikrobno testiranje i njegov utjecaj na ne-ljudske primatima u pretkliničkim DMPK studijama https://ba.prisysbiotech.com/uploads/39406/news/n20250325170337bc1d3.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17301885504414720.html Model endometrioze Cynomolgus Monkey za napredovanje terapijskog istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://ba.prisysbiotech.com/news/membranous-nephropathy-model-17301885277299712.html Unapređenje membranske nephropatije (MN) Razvoj droga: Prisys Biotech's Cynomolgus Monkey Model Platform https://img01.v15cdn.com/gallery/4x3/148.webp https://ba.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17301885393789952.html Farmakokinetika udisanih lijekova: paradigmi prelazak iz sistemskog do plućne izloženosti https://ba.prisysbiotech.com/uploads/39406/news/n20250310174924e6965.png https://ba.prisysbiotech.com/news/animal-models-for-womens-health-17301885268157440.html Prisys Biotech: životinjski modeli za žensko zdravlje terapije https://ba.prisysbiotech.com/uploads/39406/news/n202503071009566b10b.png https://ba.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17301920933585920.html Svjetski dan pretilosti|Prisys BIOTECH NHP metabolički modeli: Pokretanje razvoja anti-gozljačkih terapija za novu generaciju https://ba.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://ba.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17301885350798336.html Prisys Biotech's Cynomolgus Monkey Psoriasis model: Napredovanje prekliničke farmakodinamičke evaluacije https://ba.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://ba.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17301885598196736.html Biopsija jetre: Ključna tehnika u velikim apotekama farmakokinetičke (PK) za novi razvoj droga https://ba.prisysbiotech.com/uploads/39406/news/n2025022509490064708.png https://ba.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17301920713745408.html Integracija farmakokinetike i farmakodinamike u razvoju lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://ba.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17301885471548416.html Šta dokaz koncepta (POC) u razvoju droga zaista potvrđuje? https://ba.prisysbiotech.com/uploads/39406/news/n20250218092412fb5f5.jpg https://ba.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17301885254607872.html Životinjski modeli|Izazovi i aplikacije u razvoju modela bola https://ba.prisysbiotech.com/uploads/39406/news/n202502141328261a025.png https://ba.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17301920912466944.html Neklinička farmakodinamička istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n2025021214305230811.jpg https://ba.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17245532641453056.html Odabir idealnog ne-ljudskog primata za toksikološke studije: Cynomolgus macaque, rezus macaque i marmoset https://ba.prisysbiotech.com/uploads/39406/news/n20250205142604591d8.jpg https://ba.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17301885352764416.html Sistemski lupus eritematosus (SLE) i uloga životinjskih modela u terapijskom razvoju https://ba.prisysbiotech.com/uploads/39406/news/n20250121104603461db.jpg https://ba.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17301885348078592.html Ne-ljudski sloj primat za reumatoidni artritis (RA) https://ba.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://ba.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17301885350634496.html Životinjski mozak stereotaktički instrumenti zasnovani na 3D koordinatnim sistemima https://ba.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://ba.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17301885369836544.html Životinjski modeli za u vivo testiranju (1): Uspostavljanje i klasifikacija https://ba.prisysbiotech.com/uploads/39406/news/n20250112202508b936b.jpg https://ba.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84036218.html Istraživanje potencijalnih puteva za ulazak bioloških tvari u mozak https://ba.prisysbiotech.com/uploads/39406/news/n202501071034417382f.png https://ba.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84036161.html Unapređenje istraživanja reumatoidnog artritisa (RA) s modelima primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://ba.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84036158.html Istraživanje životinjskih modela za efikasnost lijekova za atopijski dermatitis https://ba.prisysbiotech.com/uploads/39406/news/n202412301624286dab0.jpg https://ba.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84036231.html Kritična uloga životinjskih modela u istraživanju ljudskih bolesti https://ba.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://ba.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84036237.html Model majmuna s nedostatkom Parkin gena otkriva nove mehanizme i terapeutske ciljeve za Parkinsonovu bolest https://ba.prisysbiotech.com/uploads/39406/news/n20241224162504c3c54.jpg https://ba.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84036169.html Vodič za razvoj nekliničkih lijekova: akutne, subakutne, subkronične i kronične studije opće toksičnosti https://ba.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://ba.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84036155.html Inovativna isporuka lijekova iz nosa u mozak (N2B): zaobilaženje krvno-moždane barijere https://ba.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://ba.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84036156.html Mogućnosti i izazovi mini svinja kao nekliničke vrste velikih životinja https://ba.prisysbiotech.com/uploads/39406/news/n2024120911110171c55.jpg https://ba.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83095944.html Strategije isporuke lijekova za bolesti mozga https://ba.prisysbiotech.com/uploads/39406/news/n202412030944155b417.jpg https://ba.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83095904.html Intraoperativna MRI navigacija u realnom vremenu: podržava FDA odobrenje prve genske terapije za nedostatak AADC https://ba.prisysbiotech.com/uploads/39406/news/n202411280914044b8c7.jpg https://ba.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83095898.html Studije očne toksičnosti kapi za oči: izloženost lijekovima i procjena sigurnosti https://ba.prisysbiotech.com/uploads/39406/news/n20241126163322d869c.jpg https://ba.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82797888.html Prisys Biotech uspostavlja model psorijaze majmuna Cynomolgus kako bi ubrzao razvoj lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2024111910582749e02.jpg https://ba.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82797893.html Sveobuhvatni modeli primata koji nisu ljudi za istraživanje bubrežnih bolesti od strane Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2024111511090891eb1.jpg https://ba.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82797895.html Sveobuhvatna pretklinička procjena sigurnosti konjugata antitijela i lijeka (ADC) kod primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/n20241111141121c84f3.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82797884.html Farmakokinetička procjena konjugata antitijela i lijeka (ADC) kod primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/n202411081401283f377.jpg https://ba.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82797883.html Farmakodinamička evaluacija ADC https://ba.prisysbiotech.com/uploads/39406/news/n20241106161502bd911.jpg https://ba.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82797890.html Razumijevanje DMPK ADC lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20241029101148c4fbd.jpg https://ba.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82797887.html Napredak u razvoju lijekova nukleinskih kiselina i istraživačke sposobnosti Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2024101713330113621.jpg https://ba.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82332900.html Napredak u sistemima plućne isporuke mRNA i inovativnim uslugama Prisys biotech https://ba.prisysbiotech.com/uploads/39406/news/n20241014090616a9ff8.jpg https://ba.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82797889.html Zašto je 2024. Nobelova nagrada za fiziologiju ili medicinu dodijeljena ova dva naučnika koji su proučavali mikroRNA? https://ba.prisysbiotech.com/uploads/39406/news/n20241008113621e90e6.jpg https://ba.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82797896.html Farmakokinetička (PK) razmatranja za lijekove centralnog nervnog sistema (CNS). https://ba.prisysbiotech.com/uploads/39406/news/n2024092913295797d3f.jpg https://ba.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656481.html Napredak u istraživanju CNS-a: Prisys Biotech-ov MRI-kompatibilan sistem za injekcije u mozak i CED tehnologija https://ba.prisysbiotech.com/uploads/39406/news/n202408062147375802b.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120826.html Unapređenje terapeutskih inovacija za krvarenje i zgrušavanje s Cynomolgus Monkey MCAO modelom https://ba.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://ba.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120825.html DMPK evaluacija lijekova za centralni nervni sistem (CNS). https://ba.prisysbiotech.com/uploads/39406/news/n20240924110059a8fdd.png https://ba.prisysbiotech.com/news/animal-models-of-human-diseases-81120830.html https://ba.prisysbiotech.com/uploads/39406/news/n20240920153353a85bd.png https://ba.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120817.html Inovacije u evaluaciji bola: analiza ponašanja vođena umjetnom inteligencijom https://ba.prisysbiotech.com/uploads/39406/news/n2024091816220958caa.png https://ba.prisysbiotech.com/news/china-experimental-monkey-industry-81120819.html Istorija, trenutni status, izazovi i mogućnosti kineske eksperimentalne industrije majmuna https://ba.prisysbiotech.com/uploads/39406/news/n20240909130237c0dc8.jpg https://ba.prisysbiotech.com/news/human-disease-animal-models-81120823.html Životinjski modeli ljudskih bolesti: ključni alat za unapređenje biomedicinskih istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n20240904101437e1414.jpg https://ba.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81121206.html Važnost pretkliničke farmakodinamike u razvoju lijekova|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202408281439443e4db.jpg https://ba.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120821.html Intranazalna primjena u studijama na životinjama https://ba.prisysbiotech.com/uploads/39406/news/n20240827104336fadf5.png https://ba.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410583.html Revolucioniranje razvoja CNS lijekova: PRISYS Biotech uvodi IMRI tehnologiju https://ba.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://ba.prisysbiotech.com/news/convection-enhanced-delivery-81120824.html Napredak precizne medicine: tehnologija poboljšane konvekcijom (CED) od Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20240822125521f1687.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120822.html Cynomolgus majmun kronična bolest bubrega (CKD) model Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://ba.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79526971.html Predklinička procjena sigurnosti primjene lijekova u oči pomoću Cynomolgus Macaques https://ba.prisysbiotech.com/uploads/39406/news/n2024080116325669291.png https://ba.prisysbiotech.com/news/compartment-pk-model-81120827.html Razumijevanje modela odjeljka i modela bez odjeljka u farmakokinetici https://ba.prisysbiotech.com/uploads/39406/news/n202408121135341dcc9.jpg https://ba.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79527026.html Uloga AAV-a u genskoj terapiji: imunološki odgovori i toksičnost https://ba.prisysbiotech.com/uploads/39406/news/n20240801163452493e1.png https://ba.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120818.html Napredne tehnike isporuke CNS-a kod Cynomolgus majmuna: Ubrzavanje razvoja oligonukleotidnih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20240809165539b61ef.jpg https://ba.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79526974.html Optimizirane strategije nekliničke evaluacije imunogenosti https://ba.prisysbiotech.com/uploads/39406/news/n2024080116353273f4d.png https://ba.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79526978.html Smanjenje upotrebe neljudskih primata u nekliničkim procjenama sigurnosti: perspektive FDA i industrije https://ba.prisysbiotech.com/uploads/39406/news/n20240801163624dabc0.png https://ba.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79527022.html LCMS pretklinička bioanaliza lijekova za gensku terapiju na bazi LNP https://ba.prisysbiotech.com/uploads/39406/news/n20240801181230b6a27.jpg https://ba.prisysbiotech.com/news/mrna-based-therapies-past-79527017.html Terapije zasnovane na MRNA: prošlost https://ba.prisysbiotech.com/uploads/39406/news/n2024080118112364d2d.jpg https://ba.prisysbiotech.com/news/pk-strategies-of-pdc-79526968.html Strategije farmakokinetičke studije konjugata peptid-lijek (PDC) https://ba.prisysbiotech.com/uploads/39406/news/n2024080109123097cb8.png https://ba.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79527014.html Farmakodinamička (PD) evaluacija genske terapije https://ba.prisysbiotech.com/uploads/39406/news/n20240801180623d1663.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527000.html Farmakokinetika i bioanaliza oligonukleotidnih lijekova-(1) https://ba.prisysbiotech.com/uploads/39406/news/n20240801180452c5c2a.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527021.html Farmakokinetika i bioanaliza oligonukleotidnih lijekova: karakteristike apsorpcije i farmakokinetike plazme (PK) https://ba.prisysbiotech.com/uploads/39406/news/n20240801180317bc744.jpg https://ba.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79527019.html Faktori koje treba uzeti u obzir za imunogenost oligonukleotidnih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n202408011801502cfb9.jpg https://ba.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79527024.html MRNA: Snažan i svestran alat za borbu protiv bolesti-Prisys-Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202408011756272a013.jpg https://ba.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79527004.html Kineski naučnici nude nove strategije za preokretanje osnovnih simptoma Parkinsonove bolesti https://ba.prisysbiotech.com/uploads/39406/news/n20240801175516ecb8a.jpg https://ba.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79526999.html Prisys Biotechnology: Nove lipidne nanočestice za isporuku MRNA kod primata https://ba.prisysbiotech.com/uploads/39406/news/n2024080117542971a31.jpg https://ba.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79526997.html Važnost istraživanja translacijske medicine od osnovnih istraživanja do kliničkih studija https://ba.prisysbiotech.com/uploads/39406/news/n20240801175156b8ed0.jpg https://ba.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79527012.html Glavni faktori koji se razmatraju u analizi WOE https://ba.prisysbiotech.com/uploads/39406/news/n20240801175020842f8.jpg https://ba.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79526992.html Kako dostaviti biološke lijekove u mozak? https://ba.prisysbiotech.com/uploads/39406/news/n20240801174910a58bb.jpg https://ba.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79526996.html Kako se lijekovi kreću i mijenjaju u našim tijelima: Kratak uvod u farmakokinetiku https://ba.prisysbiotech.com/uploads/39406/news/n202408011748076fca9.jpg https://ba.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79527001.html Kako brže i sigurnije razviti nove lijekove: Vodič za pretkliničke DMPK studije https://ba.prisysbiotech.com/uploads/39406/news/n2024080117445005c7b.jpg https://ba.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79527020.html Smjernice za grupni smještaj za laboratorijske majmune https://ba.prisysbiotech.com/uploads/39406/news/n2024080117440822f67.jpg https://ba.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79527010.html Vitalna uloga eksperimentalnih majmuna u unapređenju naučnih istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n20240801174211d2a1b.jpg https://ba.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79527013.html Razumijevanje Macaca Fascicularis (Majmun Cynomolgus): ključne karakteristike i doprinosi biomedicinskim istraživanjima https://ba.prisysbiotech.com/uploads/39406/news/n20240801174043f9c14.jpg https://ba.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79526998.html Revolucioniranje liječenja metaboličkih bolesti: Napredak i izazovi u razvoju peptidnih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2024080117395084c9b.jpg https://ba.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79526995.html Kako procijeniti sigurnost proizvoda za kožu prije kliničkih ispitivanja? https://ba.prisysbiotech.com/uploads/39406/news/n20240801173853b9e8e.jpg https://ba.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79527009.html Značajna uloga eksperimentalnih majmuna u inovativnom razvoju lijekova: pogled iznutra na posao https://ba.prisysbiotech.com/uploads/39406/news/n20240801173640dbcdb.jpg https://ba.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79527016.html Toksičnost jetre kao ključna briga za lijekove SiRNA: sveobuhvatna analiza Specifičnost cilja: mač s dvije oštrice SiRNA https://ba.prisysbiotech.com/uploads/39406/news/n20240801173252513ea.jpg https://ba.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79526991.html Unapređenje terapije SiRNA: prevazilaženje izazova u razvoju lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2024080117311060b15.jpg https://ba.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79526981.html Izgledi primjene genskih lijekova na bazi lipidnih nanočestica https://ba.prisysbiotech.com/uploads/39406/news/n20240801172808b0a45.jpg https://ba.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79527006.html Ključne točke u dizajniranju strategija za nekliničke studije na maloljetnim životinjama https://ba.prisysbiotech.com/uploads/39406/news/n20240801172702f375a.jpg https://ba.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79526988.html Uvid u senzorne i bihevioralne osobine neljudskih primata (NHP) https://ba.prisysbiotech.com/uploads/39406/news/n2024080117261321519.jpg https://ba.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79527015.html Pitanja i odgovori o evaluaciji predkliničkih studija https://ba.prisysbiotech.com/uploads/39406/news/n20240801172429e1895.jpg https://ba.prisysbiotech.com/news/significance-principles-and-requirements-of-79527851.html Značaj, principi i zahtjevi sigurnosno-farmakološkog istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n2024080117231644f61.jpg https://ba.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79527835.html Kako procijeniti pretkliničku farmakološku efikasnost? https://ba.prisysbiotech.com/uploads/39406/news/n20240801172217a2b22.jpg https://ba.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79527003.html Razmišljanja o nekliničkim farmakološkim studijama i evaluaciji terapijskih lijekova za nealkoholni steatohepatitis (NASH) https://ba.prisysbiotech.com/uploads/39406/news/n202408011720005c93e.jpg https://ba.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79526976.html Unapređenje istraživanja CNS-a i CGT-a: Prisys Biotechnologies Leading The Way https://ba.prisysbiotech.com/uploads/39406/news/n202408011718404c246.jpg https://ba.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79526993.html Smjernice za prikupljanje cerebrospinalne tekućine ne-humanog primata https://ba.prisysbiotech.com/uploads/39406/news/n20240801171318f7961.jpg https://ba.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79526980.html Razmatranja za tumačenje podataka o kliničkoj patologiji kod neljudskih primata (NHP) i očnjaka https://ba.prisysbiotech.com/uploads/39406/news/n2024080117122736428.jpg https://ba.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79526970.html ​​​​​Integriranje procjene sigurnosti CNS-a u opće toksikološke studije https://ba.prisysbiotech.com/uploads/39406/news/n2024080117110558056.jpg https://ba.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79526990.html Kako provesti pretkliničku farmakološku/toksikološku evaluaciju ADC-a? https://ba.prisysbiotech.com/uploads/39406/news/n20240801170828e5c98.jpg https://ba.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526975.html ADME uvid u oligonukleotidne lijekove (1) - apsorpcija, distribucija https://ba.prisysbiotech.com/uploads/39406/news/n202408011705192b402.jpg https://ba.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526985.html ADME uvid u oligonukleotidne lijekove (2) - metabolizam i izlučivanje https://ba.prisysbiotech.com/uploads/39406/news/n20240801164818e22a4.jpg https://ba.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79526967.html Pretkliničke studije na životinjama (1) - životinjske vrste https://ba.prisysbiotech.com/uploads/39406/news/n202408011646162c426.jpg https://ba.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79526972.html Izazovi i strategije interpretacije podataka kliničke patologije u pretkliničkim studijama pasa i primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/n20240801164503e9bd9.jpg https://ba.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79527005.html Pretkliničke studije na životinjama (2) - Rute i količine administracije https://ba.prisysbiotech.com/uploads/39406/news/n20240801163712d0df1.jpg https://ba.prisysbiotech.com/news/mrna-based-therapies-present-79527023.html Terapije zasnovane na MRNA: prisutne https://ba.prisysbiotech.com/uploads/39406/news/n2024080118104113739.jpg https://ba.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79527018.html Terapije zasnovane na MRNA: budućnost i izazovi https://ba.prisysbiotech.com/uploads/39406/news/n2024080118092133eb2.jpg https://ba.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79527007.html Kratak uvod o biološkoj analizi genske terapije https://ba.prisysbiotech.com/uploads/39406/news/n202408011807079dc4e.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410582.html Cynomolgus majmun u istraživanju oftalmoloških lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2024072509180742b12.png https://ba.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410584.html Translacijske i unakrsno reaktivne studije s Prisysovim NHP modelima imunologije i upale https://ba.prisysbiotech.com/uploads/39406/news/n2024072212200879ff1.png https://ba.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79185738.html Nenaivni NHP u pretkliničkim ispitivanjima: isplativo rješenje Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2024071618013071b40.png https://ba.prisysbiotech.com/news/nhp-asthma-model-79185740.html NHP model astme: osnaživanje pretkliničkih studija efikasnosti lijekova uz Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202407051359254acc6.png https://ba.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79185737.html Napredak u istraživanju imunologije i upale s modelima Cynomolgus Macaques - Prisys Biotechnologies https://ba.prisysbiotech.com/uploads/39406/news/n20240703110911ef80e.png https://ba.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79185733.html Direktna isporuka oligonukleotidnih lijekova u CNS i uobičajene histopatološke promjene https://ba.prisysbiotech.com/uploads/39406/news/n202406131052303d31d.png https://ba.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79185736.html Intracerebrovaskularni moždani udar (ICH) model Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20240607164926587f9.png https://ba.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75171612.html Neklinička farmakodinamička istraživanja: esencijalni aspekt u razvoju SiRNA lijekova https://ba.prisysbiotech.com/uploads/39406/news/n202402211320123fe5b.jpg https://ba.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77721114.html MRI vođeni centralni nervni sistem velikih životinja Precizna lokalizacija i sistem isporuke se smjestio u Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://ba.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77063225.html Inovativna rješenja za unapređenje respiratorne terapije https://ba.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://ba.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74804003.html Prisys: Unapređenje eksperimentiranja na životinjama kroz studije Cynomolgus Macaquea https://ba.prisysbiotech.com/uploads/39406/news/n202402271423376ec81.png https://ba.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76183587.html Prisys postiže punu akreditaciju od strane AAALAC International: prekretnica u osiguravanju visokih standarda njege laboratorijskih životinja. https://img01.v15cdn.com/gallery/4x3/265.webp https://ba.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74677650.html Podizanje terapije nukleinskim kiselinama kroz najsavremenije sa Prisys Biotech neljudskim modelima primata https://ba.prisysbiotech.com/uploads/39406/news/n202401261332041ba3c.jpg https://ba.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74175477.html Revolucioniranje CNS isporuke lijekova: Prisys i obećanje intratekalne injekcije https://ba.prisysbiotech.com/uploads/39406/news/n20240111101138bd6a1.jpg https://ba.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75171609.html Prisys Biotech 2024 Q1 Newsletter - vaš pouzdani specijalista za studije neljudskih primata https://ba.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://ba.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73544250.html Kako ultrazvučno vođena biopsija jetre poboljšava istraživanje zasnovano na makaku https://ba.prisysbiotech.com/uploads/202339406/n202312211047254501881.jpg https://ba.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73544249.html Smjernice za doživotnu upotrebu neljudskih primata u biomedicinskim istraživanjima: Prisys biotehnološka perspektiva https://ba.prisysbiotech.com/uploads/39406/news/n202402271428388db72.png https://ba.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73023878.html Primati koji nisu ljudi: Kratak uvod u njihove biološke karakteristike https://ba.prisysbiotech.com/uploads/39406/news/n202402271431193773d.png https://ba.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72679086.html Pregled izložbe|Prisys Biotech blista na godišnjem sastanku Američkog društva za neuronauku (SfN 2023) https://ba.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://ba.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321957.html Upoznajte Prisys Biotech na godišnjem sastanku Društva za neuronauku (SfN 2023) https://ba.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://ba.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321959.html Svjetski dan borbe protiv moždanog udara|Fokus na životinjske modele i farmakologiju ishemijskog moždanog udara https://ba.prisysbiotech.com/uploads/202339406/n202310292017544133660.jpg https://ba.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321955.html Prisys Biotech vas poziva da prisustvujete godišnjem sastanku SAPA-Kina 2023. https://ba.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://ba.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321960.html Svjetski dan Alchajmerove bolesti|Izazovi i rješenja za razvoj AD lijekova https://ba.prisysbiotech.com/uploads/202339406/n202309211504565472671.jpg https://ba.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321958.html Prisys Biotechov životinjski model Cynomolgus Macaque pomaže u razvoju novih antikoagulansa https://ba.prisysbiotech.com/uploads/202339406/n202309182207050266461.png https://ba.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71069030.html Prisys: Pružanje visokokvalitetnih usluga eksperimenata na životinjama za novo antikoagulacijsko faktor XI antitijela BJTJ-1837 https://ba.prisysbiotech.com/uploads/202339406/n202308311332528401166.jpg https://ba.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71069028.html Metoda za uspostavljanje modela hipertrigliceridemije Cynomolgus majmuna i njegova primjena https://ba.prisysbiotech.com/uploads/202339406/n202308212156285814136.jpg https://ba.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71069031.html Farmakologija: glavni parametri i značaj farmakokinetike (PK) https://ba.prisysbiotech.com/uploads/202339406/n202308091145033318894.jpg https://ba.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71069027.html Preklinička farmakološka evaluacija lijekova protiv onkolitičkih virusa https://ba.prisysbiotech.com/uploads/202339406/n202308071041585027430.jpg https://ba.prisysbiotech.com/news/0-71069029.html Kako lijekovi male nukleinske kiseline mogu transformirati liječenje bolesti CNS-a: uvidi iz Prisys biotehnologije, vodećeg CRO dobavljača NHP modela bolesti https://ba.prisysbiotech.com/uploads/202339406/n202308041018581481730.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71069032.html Farmakokinetika, istraživačke strategije i studije slučaja peptidnih lijekova https://ba.prisysbiotech.com/uploads/202339406/n202308031715493686411.jpg https://ba.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69666129.html Ključne tačke istraživanja ADC Drug PK https://ba.prisysbiotech.com/uploads/202339406/n202307302137108622628.jpg https://ba.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69657523.html Prisys Biotechnology: Lider u NHP CNS platformi za modeliranje bolesti https://ba.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://ba.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309409.html Kako smršaviti i kontrolisati dijabetes uz GLP{0}} proizvode https://ba.prisysbiotech.com/uploads/202339406/n202307162139405018976.jpg https://ba.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309388.html Kako kineski majmun pomaže u provođenju predkliničkih istraživanja efikasnosti? https://ba.prisysbiotech.com/uploads/39406/news/n20240227143532bd79a.png https://ba.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309275.html Koja je efikasnost RNAi? https://ba.prisysbiotech.com/uploads/202339406/n202307092210201669077.jpg https://ba.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309368.html Prisys Biotech Large Animal Experiment Platforma javnih usluga: jeftino i visoko efikasno rješenje za velike eksperimente na životinjama https://ba.prisysbiotech.com/uploads/39406/news/n2024022714394317bcf.png https://ba.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69015520.html Kako AAV genska terapija može spasiti vaš vid: Najnovija otkrića studija o primatima koji nisu ljudi https://ba.prisysbiotech.com/uploads/202339406/n202307022231508642715.jpg https://ba.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69015391.html Prisys Biotech prikazuje platformu modela neljudskih primata na godišnjem sastanku Japanskog društva za toksikologiju https://ba.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://ba.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69018283.html Obećavajuća budućnost AAV genske terapije kod primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/202339406/n202306232107539553735.jpg https://ba.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69017706.html Šta su lipidne nanočestice za gensku terapiju? https://ba.prisysbiotech.com/uploads/202339406/n202306182144004132789.jpg https://ba.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69015625.html Prisys Biotech vas poziva da učestvujete na 50. godišnjem sastanku Japanskog društva za toksikologiju (JSOT) https://ba.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://ba.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69018386.html Test imunotoksičnosti, procjena sigurnosti lijekova-PRISYS BIOTECH https://ba.prisysbiotech.com/uploads/202339406/n202306102132091628389.jpg https://ba.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306711.html Optimalni životinjski model ishemijskog moždanog udara ustanovljen autolognim trombi vođenim digitalnom subtrakcionom angiografijom u Cynomolgus majmuna https://ba.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://ba.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68116090.html Zašto biste trebali brinuti o primatima koji nisu ljudi u istraživanju i razvoju sistema za isporuku lijekova nukleinske kiseline https://ba.prisysbiotech.com/uploads/202339406/n202305282122338248983.jpg https://ba.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68116088.html Upoznajte Prisys Biotech na 70. JALAS-u 2023! https://ba.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://ba.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68116954.html Genska terapija blista s novim odobrenjima za rijetke bolesti https://ba.prisysbiotech.com/uploads/202339406/n202305162133347179081.jpg https://ba.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68116089.html Revolucioniranje otkrića droga: Kako primati koji nisu ljudi optimiziraju SiRNA skrining za brže i efikasnije rezultate https://ba.prisysbiotech.com/uploads/39406/news/n20240227144111404cb.png https://ba.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67550071.html Maksimiziranje farmakološke efikasnosti SiRNA uz istraživanje primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/202339406/n202305022215194112233.jpg https://ba.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67549433.html Kako neljudski primati mogu revolucionirati istraživanje SiRNA: sveobuhvatni vodič https://ba.prisysbiotech.com/uploads/202339406/n202304272138362221911.jpg https://ba.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67548171.html Obilježavanje Svjetskog dana laboratorijskih životinja: Zašto je Prisys posvećen promicanju zdravlja primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://ba.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67552109.html Maksimiziranje CRISPR/Cas9 istraživačke efikasnosti uz modele neljudskih primata https://ba.prisysbiotech.com/uploads/202339406/n202304221149520486556.jpg https://ba.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67547576.html Oslobađanje terapeutskog potencijala: Zašto je ulaganje u lijekove nukleinske kiseline budućnost medicine https://ba.prisysbiotech.com/uploads/202339406/n202304200850383332884.jpg https://ba.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67562280.html Otključavanje potencijala neljudskih primata u poboljšanju otkrivanja ciljanih lijekova genskom terapijom https://ba.prisysbiotech.com/uploads/202339406/n202304142148160397375.jpg https://ba.prisysbiotech.com/news/world-parkinsons-disease-day-67546934.html Ujedinite se za Parkinsonovu bolest: Udruživanje ruku radi podizanja svijesti na Svjetski dan Parkinsonove bolesti https://ba.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://ba.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67548172.html Kako efikasno koristiti primate koji nisu ljudi u procjeni sigurnosti genske terapije https://ba.prisysbiotech.com/uploads/202339406/n202304102117431547381.jpg https://ba.prisysbiotech.com/news/gene-therapy-toxicology-66274458.html Toksikološko istraživanje genske terapije s Nonhuam Primate https://ba.prisysbiotech.com/uploads/202339406/n202304052050241172289.jpg https://ba.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66128263.html Sveobuhvatni vodič za provođenje DMPK studije za gensku terapiju https://ba.prisysbiotech.com/uploads/202339406/n202303292053463875854.jpg https://ba.prisysbiotech.com/news/gene-therapy-nhp-model-66127932.html Revolucioniranje medicinskog istraživanja: Proboj genske terapije u modelima bolesti neljudskih primata! https://ba.prisysbiotech.com/uploads/202339406/n202303282057377312705.jpg https://ba.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66127937.html Top 10 popularnih pitanja vezanih za gensku terapiju https://ba.prisysbiotech.com/uploads/202339406/n202303241229248740600.jpg https://ba.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66127939.html Prisys Biotech: Farmakologija neljudskih primata za gensku terapiju https://ba.prisysbiotech.com/uploads/202339406/n202303241128310077112.jpg https://ba.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66127547.html Podrška zdravlju žena: Pogled na endometriozu https://ba.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://ba.prisysbiotech.com/news/prisys-sot2023-66127548.html PRISYS i Taichu grupa sarađuju na izložbi SOT 2023 https://ba.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://ba.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66127542.html Do We Need Further Studies For Pain Assessment? - NHP https://ba.prisysbiotech.com/uploads/202339406/n202303081329477852711.jpg https://ba.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66127545.html Pridružite nam se u obilježavanju Svjetskog dana divljih životinja https://ba.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://ba.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66127544.html Pokreće Prisys Shanghai NHP R&D centar, označavajući prekretnicu u farmaceutskom istraživanju i razvoju u Kini https://ba.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://ba.prisysbiotech.com/news/meetprisys-sot2023-66127543.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://ba.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg